Since first hitting the market in 2007, Vyvanse, a stimulant medication used primarily to treat attention-deficit/hyperactivity disorder, is a unique and increasingly sought after drug. While it’s costly, it’s one of the most commonly prescribed and effective alternatives to the well-known Adderall.
By the end of August, 2023 Vyvanse which is also referred to under its generic name dimesylate lisdexamfetamine, will lose its exclusivity in the market. This means it is possible to make generic variants of extremely expensive brand name drug will soon be manufactured and sold which will result in cheaper alternatives for those who require it.
What is the best time to be expecting the less expensive version? What does this have to do with those who are suffering from this Adderall shortage?
What is generic drugs?
As with most items you purchase, medicines are available in generic and brand-name versions. Brand name drugs are generally more expensive and therefore manufacturers create generic versions of their original formula in order to offer people cheaper alternatives.
When pharmaceutical companies develop medicines, they seek patents for their formulations. Additionally, they create exclusivity periods that grant them the exclusive right to develop and market the product for an agreed-upon period of time. After the exclusivity period for a particular drug expires, other pharmaceutical companies are able to offer substitute versions for the product at a lower price.
What are the main things that people who take Vyvanse be expecting?
If you are taking Vyvanse currently or anticipate taking it in the near future however, it could take some time before a cheaper alternative is on the counter.
The patent on buying vyvanse online from Takeda Pharmaceutical expired in February however, the company is granted the privilege of having exclusivity for six months (until august) as the sole Lisdexamfetamine producer.
On August 24 on August 24, the FDA will look into approval of generic lisdexamfetamine formulas that are made by different manufacturers. At present, Vyvanse will remain the only drug that is of this kind on the market.
When will you have access to generic versions of Vyvanse? It’s hard to know: In order for a brand-new drug to be put available for sale and available for sale, the FDA states that the manufacturer must conduct clinical tests for “validate that it’s safe, effective and can be a substitute for the brand-name” version. After that, they’re able to make it available to the FDA for FDA approval.
Clinical trials can last for several years. Even if some studies using generic lisdexamfetamine are currently under development The generic drugs have to go through the FDA approval process.
If the manufacturer has proven that the drug to be safe and efficient the procedure to accept an application to approve an innovative drug generally is under six months. The earliest you can anticipate that new generics of lisdexamfetamine that will be accessible for purchase is the end of 2023 or even early 2024.
Adderall and Vyvanse adverse effects
The most frequent adverse effects of Mydayis and Vyvanse in adolescents, children or adults suffering from ADHD are:
Upper abdominal discomfort, stomach pain vomiting, loss appetite, weight loss and constipation, diarrhea
Tics in the motor (repeated movement of the muscles)
Heart rate increases
In rare cases, Mydayis and Vyvanse can produce more serious adverse negative effects. This includes:
Serious cardiovascular reactions e.g. chest pain
Sudden death has been reported in CNS stimulant treatment in dosages that are recommended for children with heart defects that are structural or serious heart conditions.
Deaths that occur suddenly, strokes and heart attacks among adults
Increase in blood pressure and a rise in heart rate
Suspression of growth – track the weight and height of pediatric patients
Circulation issues, like changing skin color, a chilling sensation, including Raynaud’s syndrome
Serotonin syndrome – a higher risk when administered in conjunction with serotonergic drugs (e.g., SSRIs, triptans, SNRIs) however, it is also a risk when there is an overdosage situation
A new or deteriorating psychosis bipolar disorder or mental health problems
When you abruptly quit taking this medication: extreme tiredness, sleep issues or mental/mood change such as depression
Allergic reactions that are severe e.g. shortness of breath, hives
Your physician will evaluate the advantages of using Mydayis and Vyvanse in comparison to the potential adverse consequences. It is recommended that you notify adverse side negative effects or adverse reactions from buy vyvanse online or Mydayis, to FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Mydayis along with Vyvanse drug interactions
Mydayis and Vyvanse may interact with other medicines which include prescription medications. In some cases it can alter the way the other medications and Mydayis work. It may also make it more likely and severe of some adverse consequences. The medications that are believed may interact with mydayis or Vyvanse include:
Monoamine oxide inhibitors, MAOIs, (methylene blue selegiline, phenelzine, or methylene blue)
Antidepressants tricyclic (desipramine and protriptyline)
The medications you take affect your serotonin systems (SSRIs and SNRI antidepressants triptans and fentanyl as well as St. John’s Wort)
Review the complete prescribing details on Mydayis as well as Vyvanse and never hesitate to speak with your physician for advice from a medical professional regarding the medicine you’re taking to assess and monitor your medical condition. Be sure to inform your doctor of any medical issues and all medications you take, including prescription and over-the-counter medications.
Vyvanse along with Mydayis are two of the most commonly prescribed ADHD medication. Both mediations are effective in helping reduce symptoms, it might require trial and error to decide which one will work best for you.
The Adderall shortage
After the expiration of Vyvanse’s exclusivity those who have been forced to discontinue using Adderall due to the shortage and also those who been forced to stop taking the medication due to other options that do not work for them may be able to think about Vyvanse generics as an alternative that is low-cost. But, this approach isn’t for everyone: Adderall and Vyvanse are two distinct drugs that have different ways of working within the body.
Patients and providers alike Vyvanse’s patent expiration will mean that there will be more readily available and effective treatments for ADHD. The date for generic versions is on the near horizon, and for many people, it’s enough.